Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Anderes K, Blasina A, Chen E, Kornmann J, Kraynov E, Stempniak M, Register J, Ninkovic S, Fleur CL, O'Connor P (2006) Characterization of a novel and selective inhibitor of checkpoint kinase 1: breaching the tumor's last checkpoint defense against chemotherapeutic agents. Eur J Cancer Suppl 4: 115
2. Arlander SJ, Eapen AK, Vroman BT, McDonald RJ, Toft DO, Karnitz LM (2003) Hsp90 inhibition depletes Chk1 and sensitizes tumor cells to replication stress. J Biol Chem 278: 52572–52577
3. Ashwell S (2007) AZD7762, a novel potent and selective inhibitor of checkpoint kinases. Drug development track special session 2: New Drugs on the Horizon 2. AACR Annual Meeting 2007; 15 April 2007; AstraZeneca Research and Development: Waltham, MA
4. Bartek J, Falck J, Lukas J (2001) CHK2 kinase – a busy messenger. Nat Rev Mol Cell Biol 2: 877–886
5. Bartek J, Lukas C, Lukas J (2004) Checking on DNA damage in S phase. Nat Rev Mol Cell Biol 5: 792–804
Cited by
293 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献